Bromazepam: Difference between revisions

From SEHK Wiki
Helen (talk | contribs)
Helen (talk | contribs)
No edit summary
Line 88: Line 88:
*hallucinations, inappropriate behavior
*hallucinations, inappropriate behavior
*twitches and tremor
*twitches and tremor
==Pharmacokinetics==
{|class="wikitable"
!style="text-align: left"| Oral bioavailability
|Bromazepam is well absorbed after oral doses.
|-
!style="text-align: left"| Onset of action
|Bromazepam is well absorbed after oral doses.
Peak plasma concentrations are reached between 0.5 and 4 hours of a dose.
|-
!style="text-align: left"| Metabolism
|Bromazepam is metabolized in the liver 
|-
!style="text-align: left"| Elimination half-life
|Bromazepam is eliminated in the urine.
It has an elimination half-life of about 17 hours (range 11 – 22 hours).
|}

Revision as of 01:59, 6 October 2020


Introduction

Bromazepam is an intermediate-acting benzodiazepine. It is used in the short-term treatment of anxiety disorders, occuring alone or associated with insomnia.

Generic Name 藥名 HA Code 藥物代碼 Classification藥物分類
Bromazepam Tablet 1.5 mg BROM01 DDA
Bromazepam Tablet 3 mg BROM02 DDA

Pronunciation

Mechanism of Action

  • Bromazepam is a benzodiazepine.
  • Gama-Aminobutyric acid (GABA) is an inhibitory neurotransmitter, acting on the GABA receptors in the central nervous system (CNS), thus inhibiting the nerve impulses.
  • Bromazepam acts on the benzodiazepine receptors in the brain and the spinal cord. Benzodiazepine receptors in the CNS are linked with GABA receptors as a complex.
  • Bromazepam by binding to the benzodiazepine receptors results in activation of the GABA-benzodiazepine receptor complex, resulting in inhibition of nerve impulses, overall depression of brain and spinal cord.
  • Thus Bromazepam use helps to promote muscle relaxation, reduce anxiety, control of convulsions and promote sleep.

Dosage

Short-term use in anxiety By mouth
  • ADULT: 3 mg two or 3 times daily
  • ELDERLY: Should not exceed 3 mg daily in divided doses
  • DEBILITATED PATIENTS: should not exceed 3 mg daily in divided doses

When the total dose is low (eg. 3 or 6 mg), to give the total dose in the evening

Side Effects

Sedative drugs, including alprazolam, have been associated with an increased risk of death.

Possible side effects include:

Very common (>10% of incidence)

or Common (1-10% of incidence)

  • Amnesia and concentration problems
  • Ataxia (especially in the elderly)
  • Confusion (especially in the elderly)
  • Drowsiness the next day
  • Dizziness
  • Muscle weakness
  • Paradoxical increase in aggression
Infrequent (0.1 -1% of incidence)
  • Dysarthria
  • Gastro-intestinal disturbances
  • Gynecomastia
  • headache
  • Hypotension
  • Incontinence
  • Urinary retention, constipation
  • Slurred speech
  • Tremor
  • Vertigo
  • Visual disturbances
Rare (<0.1% of incidence)
  • Apnoea
  • Blood disorder
  • Jaundice
  • Respiratory depression
  • hypersensitivity reactions

Minor elevations of liver enzymes occurred in about 3% of patients.

Overdosage can produce CNS depression and coma.

Paradoxical reactions

Although unusual, the following paradoxical reactions have been shown to occur:

  • aggression, rage
  • mania, agitation, and restlessness
  • hallucinations, inappropriate behavior
  • twitches and tremor

Pharmacokinetics

Oral bioavailability Bromazepam is well absorbed after oral doses.
Onset of action Bromazepam is well absorbed after oral doses.

Peak plasma concentrations are reached between 0.5 and 4 hours of a dose.

Metabolism Bromazepam is metabolized in the liver
Elimination half-life Bromazepam is eliminated in the urine.

It has an elimination half-life of about 17 hours (range 11 – 22 hours).